Agile bristles after FDA’s third snub, promising a fight for its contraceptive

Agile Therapeutics is starting to get testy after suffering yet another snub from the FDA, announcing this morning that it simply doesn’t agree with the regulators’ assertion that its contraception patch is faulty.